Merger could make East Bay company 5th-largest generic drug maker
Generic drug maker Impax Laboratories Inc. will merge with privately held Amneal Pharmaceuticals LLC in a deal creating a company with a value of more than $6 billion, the company said Tuesday.
Impax shareholders — a list that has included BlackRock Inc. and the Vanguard Group — will own 25 percent of the combined company, which will be the fifth-largest U.S. generic drug maker.
Shanghai Fosun Pharmaceuticals reported its 5.2 percent stake in Impax in August.
The deal comes as the generic…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news